Molecular & evolutionary genetics & drug resistance of the gastric pathogen, Helicobacter pylori

Indian Journal of Medical Research

Volumn 115, Issue MAR., 2002, Pages 73-101

  Datta, S ^a   Chowdhury, A ^b   Mukhopadhyay, A K ^c   Bhattacharyal, D E ^a   Berg, S K ^c   Nair, G B ^a,d  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ICDDRB Laboratory Sciences Division   (Bangladesh)

Author keywords

Cag pathogenicity island; Genetic diversity; Ice A1; Urease; Vacuolating cytotoxin

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH SALT; CLARITHROMYCIN; HELICOBACTER PYLORI VACCINE; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; CHILDHOOD DISEASE; COST EFFECTIVENESS ANALYSIS; DNA SEQUENCE; DRUG POTENCY; DRUG SENSITIVITY; ERADICATION THERAPY; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST PARASITE INTERACTION; HUMAN; INDIA; MOLECULAR EVOLUTION; NONHUMAN; PEPTIC ULCER; REVIEW; RISK FACTOR; STOMACH CANCER; STOMACH MUCOSA;

DRUG RESISTANCE, MICROBIAL; EVOLUTION, MOLECULAR; HELICOBACTER PYLORI;

EID: 0036060018     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (248)

1. The incidence of Helicobacter pylori infection
2. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in Peptic Ulcer Disease
3. The role of Helicobacter pylori infection in duodenal and gastric ulcer
4. Helicobacter pylori and gastric adenocarcinoma
5. Impact of infection by Helicobacter pylori on the risk and severity of endemic cholera
6. Helicobacter pylori and epidemic Vibrio cholerae O1 infection in Peru
7. Helicobacter pylori infection, gastric acid secretion, and infant growth
8. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
9. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
10. Attempt to fulfil Koch's postulates for pyloric Campylobacter
11. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH
12. Long-term follow up of voluntary ingestion of Helicobacter pylori
13. Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: Implications for human disease
14. Natural gastric infection with Helicobacter pylori in monkeys: A model for spiral bacteria infection in humans
15. Campylobacter pylori in peptic ulcer disease. II. Endoscopic findings and cultivation of C. pylori
16. Campylobacter pylori infection and its relation to chronic gastritis. An endoscopic, bacteriologic, and histomorphologic study
17. Unusual cellular fatty acids and distinctive ultrastructure in a new spiral bacterium (Campylobacter pyloridis) from the human gastric mucosa
18. An ultrastructural study of the gastric campylobacter-like organism 'Campylobacter pyloridis'
19. The relationship between Helicobacter pylori motility, morphology and phase of growth: Implications for gastric colonization and pathology
20. Virulence of coccoid and bacillary forms of Helicobacter pylori in gnotobiotic piglets
21. Survival of Helicobacter pylori in water and saline
22. Bactericidal and morphological effects of amoxicillin on Helicobacter pylori
23. The coccoid forms of Helicobacter pylori. Criteria for their viability
24. Morphological transformation of Helicobacter pylori during prolonged incubation: Association with decreased acid resistance
25. Helicobacter pylori: A fickle germ
26. Affinity of the gastric pathogen Helicobacter pylori for the N-sulphated glycosaminoglycan heparan sulphate
27. Electron microscopic study of association between coccoid forms of Helicobacter pylori and gastric epithelial cells
28. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins
29. Oxidative metabolism in nonculturable Helicobacter pylori and Vibrio vulnificus cells studied by substrate-enhanced tetrazolium reduction and digital image processing
30. Structure, function and localization of Helicobacter pylori urease
31. The human gastric colonizer Helicobacter pylori: A challenge for host-parasite glycobiology
32. Helicobacter pylori pathogenesis
33. Kinetics and mechanisms of extracellular protein release by Helicobacter pylori
34. Taxonomy of Helicobacter genus
35. Natural acquisition and spontaneous elimination of Helicobacter pylori infection: Clinical implications
36. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States
37. Helicobacter pylori infection in children of Texas
38. Helicobacter pylori status in duodenal ulcer and gastric carcinoma
39. Epidemiology of Helicobacter pylori: The Indian scenario
40. H. pylori in non-ulcer dyspepsia (NUD)
41. Age-related prevalence of Helicobacter pylori antibodies in Indian subjects
42. 13C urea breath test to assess Helicobacter pylori infection in school children
43. Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies
44. Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication
45. One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease
46. A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China)
47. Intrafamilial clustering of Helicobacter pylori infection
48. Free recombination within Helicobacter pylori
49. Emergence of recombinant strains of Helicobacter pylori during human infection
50. PCR identification of Helicobacter pylori in faeces from gastritis patients
51. Isolation of Helicobacter pylori from vomitus in children and its implication in gastro-oral transmission
52. Fecal and oral shedding of Helicobacter pylori from healthy infected adults
53. Presence of Helicobacter pylori in gastric juice
54. Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction
55. Identification by PCR of Helicobacter pylori in subgingival plaque of adult periodontitis patients
56. Quantitative culture of Helicobacter pylori from gastric juice: The potential for transmission
57. Isolation of Helicobacter pylori from human faeces
58. Histological classification of gastritis and Helicobacter pylori infection: An agreement at last? The International Workshop on the Histopathology of Gastritis
59. Campylobacter pyloridis associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment
60. Pathology of gastritis and peptic ulceration
61. Long-term sequelae of Helicobacter pylori gastritis
62. Host specificity of Helicobacter pylori strains and host responses in experimentally challenged nonhuman primates
63. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil
64. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis
65. Gastric epithelium in the duodenum: Its association with Helicobacter pylori and inflammation
66. Helicobacter pylori infection and the risk of gastric carcinoma
67. The sequelae and course of chronic gastritis during a 30- to 34-year bioptic follow up study
68. Atrophic gastritis and its sequelae. Results of 19-23 years follow up examinations
69. An international association between Helicobacter pylori infection and gastric cancer
70. Epidemiology of gastric cancer
71. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii
72. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China
73. In search of the Helicobacter pylori VacA mechanism of action
74. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting
75. Genetic diversity of Helicobacter pylori
76. Recombination and clonal groupings within Helicobacter pylori from different geographical regions
77. The complete genome sequence of the gastric pathogen Helicobacter pylori
78. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
79. Differential genome analysis applied to the species-specific features of Helicobacter pylori
80. Contributions of genome sequencing to understanding the biology of Helicobacter pylori
81. The Helicobacter pylori genome sequence: Genetic factors for long life in the gastric mucosa
82. Isolation and characterization of the nikR gene encoding a nickel-responsive regulator in Escherichia coli
83. Regulation of ferritin-mediated cytoplasmic iron storage by the ferric uptake regulator homolog (Fur) of Helicobacter pylori
84. Cloning and characterization of the fur gene from Helicobacter pylori
85. Motility of Helicobacter pylori is coordinately regulated by the transcriptional activator FlgR, an NtrC homolog
86. Heat shock proteins of Helicobacter pylori
87. Characterization of an acidic-pH inducible stress protein (hsp 70), a putative sulfatide binding adhesin, from Helicobacter pylori
88. Cloning and expression of the dnaK gene of Campylobacter jejuni and antigenicity of heat shock protein 70
89. Intercellular communication in Helicobacter pylori: LuxS is essential for the production of an extracellular signaling molecule
90. Evidence for a signaling system in Helicobacter pylori: Detection of a luxS-encoded autoinducer
91. Comparative genomics of Helicobacter pylori: Analysis of the outer membrane protein families
92. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging
93. Conservation, localization and expression of HopZ, a protein involved in adhesion of Helicobacter pylori
94. r 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori
95. Isolation and characterization of a family of porin proteins from Helicobacter pylori
96. Identification of type II restriction and modification systems in Helicobacter pylori reveals their substantial diversity among strains
97. Restriction-modification system differences in Helicobacter pylori are a barrier to interstrain plasmid transfer
98. Specificities of eleven different DNA methyltransferases of Helicobacter pylori strain 26695
99. Adherence to gastric epithelial cells induces expression of Helicobacter pylori gene, iceA that is associated with clinical outcome
100. Novel sequence organization and insertion specificity of IS605 and IS606: Chimaeric transposable elements of Helicobacter pylori
101. DNA sequence conservation and diversity in transposable element IS605 of Helicobacter pylori
102. Functional organization and insertion specificity of IS607, a chimeric element of Helicobacter pylori
103. Transposable element IS Hp608 of Helicobacter pylori: Nonrandom geographic distribution, functional organization, and insertion specificity
104. Genetic organization of a small cryptic plasmid of Helicobacter pylori
105. Characterization of a plasmid from Helicobacter pylori encoding a replication protein common to plasmids in Gram-positive bacteria
106. A stable shuttle vector system for efficient genetic complementation of Helicobacter pylori strains by transformation and conjugation
107. Sequence and gene expression analyses of plasmid pHPM8 from Helicobacter pylori reveal the presence of two operons with putative roles in plasmid replication and antibiotic activity
108. Genetic competence in Helicobacter pylori: Mechanisms and biological implications
109. Evidence for a conjugation-like mechanism of DNA transfer in Helicobacter pylori
110. Molecular genetic basis for the variable expression of Lewis Y antigen in Helicobacter pylori: Analysis of the alpha (1,2) fucosyltransferase gene
111. Identification of virulence genes of Helicobacter pylori by random insertion mutagenesis
112. Green fluorescent protein as a novel marker and reporter system in Helicobacter sp
113. cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells
114. Proteome analysis: Biological assay or data archive?
115. Helicobacter pylori infection activates NF-κB in gastric epithelial cells
116. Molecular cloning and characterization of the Helicobacter pylori fliD gene, an essential factor in flagellar structure and motility
117. Development of a mouse model of Helicobacter pylori infection that mimics human disease
118. Establishment of gastric Helicobacter pylori infection in Mongolian gerbils
119. Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains
120. Gastritis induced by Helicobacter pylori in gnotobiotic piglets
121. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys
122. Motility as a factor in the colonisation of gnotobiotic piglets by Helicobacter pylori
123. Campylobacter pylori virulence factors in gnotobiotic piglets
124. Ultrastructure and biochemical studies of the flagellar sheath of Helicobacter pylori
125. Helicobacter pylori motility
126. Non-motile mutants of Helicobacter pylori and Helicobacter mustelae defective in flagellar hook production
127. Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes
128. Infection of the ferret stomach by isogenic flagellar mutant strains of Helicobacter mustelae
129. Cloning and genetic characterization of a Helicobacter pylori flagellin gene
130. Cloning and genetic characterization of the Helicobacter pylori and Helicobacter mustelae fla B flagellin genes and construction of H. pylori flaA- and flaB-negative mutants by electroporation-mediated allelic exchange
131. Purification and characterization of urease from Helicobacter pylori
132. Characterization of the Helicobacter pylori urease and purification of its subunits
133. Purification and N-terminal analysis of urease from Helicobacter pylori
134. Nucleotide sequence of two genes from Helicobacter pylori encoding for urease subunits
135. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity
136. Expression of Helicobacter pylori urease genes in Escherichia coli grown under nitrogen-limiting conditions
137. Helicobacter pylori nickel-transport gene nixA: Synthesis of catalytically active urease in Escherichia coli independent of growth conditions
138. Expression of the Helicobacter pylori ureI gene is required for acidic pH activation of cytoplasmic urease
139. + - Gated urea channel: The link between Helicobacter pylori urease and gastric colonization
140. Identification of loci essential for the growth of Helicobacter pylori under acidic conditions
141. Trefoil peptides are unique chemotaxins for Helicobacter pylori
142. Urease-independent chemotactic responses of Helicobacter pylori to urea, urease inhibitors, and sodium bicarbonate
143. Chemotaxis of H. pylori in presence of human plasma
144. Motility, chemotaxis and flagella
145. Urease plays an important role in the chemotactic motility of Helicobacter pylori in a viscous environment
146. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis
147. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens
148. Expression of a human alpha-1, 3/4- fucosyltransferase in the pit cell lineage of FVB/N mouse stomach results in production of Leb-containing glycoconjugates: A potential transgenic mouse model for studying Helicobacter pylori infection
149. Helicobacter pylori attaches to NeuAc alpha 2,3 Gal beta 1,4 glycoconjugates produced in the stomach of transgenic mice lacking parietal cells
150. A flagellar sheath protein of Helicobacter pylori is identical to HpaA, a putative N-acetylneuraminyllactose-binding hemagglutinin, but is not an adhesin for AGS cells
151. The putative neuraminyllactose-binding hemagglutinin HpaA of Helicobacter pylori CCUG 17874 is a lipoprotein
152. Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori
153. Epithelial attachment alters the outcome of Helicobacter pylori infection
154. Hypothesis: The changing relationships of Helicobacter pylori and humans: Implications for health and disease
155. In a world of black and white, Helicobacter pylori is gray
156. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration
157. Analyses of the cag pathogenicity island of Helicobacter pylori
158. Helicobacter pylori - A conundrum of genetic diversity
159. Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia
160. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan
161. cagA-positive Helicobacter pylori populations in China and The Netherlands are distinct
162. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori
163. Purification and characterization of the vacuolating toxin from Helicobacter pylori
164. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori
165. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains
166. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease
167. Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin
168. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: Structural similarities with the IgA protease type of exported protein
169. Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly
170. Heterogeneity in levels of vacuolating cytotoxin gene (vacA) transcription among Helicobacter pylori strains
171. Natural diversity in the N terminus of the mature vacuolating cytotoxin of Helicobacter pylori determines cytotoxin activity
172. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity
173. Binding of the Helicobacter pylori vacuolating cytotoxin to target cells
174. Lipid interaction of the 37-kDa and 58-kDa fragments of the Helicobacter pylori cytotoxin
175. Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant
176. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayer at low pH
177. Structure and interaction of VacA of Helicobacter pylori with a lipid membrane
178. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity
179. Inhibition of the vacuolating and anion channel activities of the VacA toxin of Helicobacter pylori
180. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases
181. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori
182. Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers
183. The acid activation of Helicobacter pylori toxin VacA: Structural and membrane binding studies
184. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA
185. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection
186. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer
187. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin
188. cag, a pathogenicity island of Helicobacter pylori encodes type I-specific and disease-associated virulence factors
189. Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India
190. Type IV secretion: Intercellular transfer of macromolecules by systems ancestrally related to conjugation machines
191. + Helicobacter pylori strains
192. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa
193. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion
194. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation
195. Altered states: Involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori
196. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein
197. The cag pathogenicity island
198. Characterization of a Helicobacter pylori neutrophil-activating protein
199. The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure
200. Sequence analysis and clinical significance of the iceA gene from Helicobacter pylori strains in Japan
201. Unique structural and biological features of Helicobacter pylori lipopolysaccharides
202. The role of lipopolysaccharide in Helicobacter pylori pathogenesis
203. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides
204. Chemical structure of lipid A from Helicobacter pylori strain 206-1 lipopolysaccharide
205. O antigen chains in the lipopolysaccharide of Helicobacter pylori NCTC 11637
206. Structural studies on lipopolysaccharides of serologically non-typable strains of Helicobacter pylori, AFI and 007, expressing Lewis antigenic determinants
207. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms
208. Molecular mimicry of host structures by lipopolysaccharides of Campylobacter and Helicobacter spp.: Implications in pathogenesis
209. Lewis X structures in the O antigen side chain promote adhesion of Helicobacter pylori to the gastric epithelium
210. Helicobacter pylori and gastric inflammation
211. Gastric mucosal inflammatory responses to Helicobacter pylori
212. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease
213. Different cytokine profile and antigen specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer
214. +-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy
215. Genotyping of Helicobacter pylori isolates by sequencing of PCR products and comparison with the RAPD technique
216. Analysis of genetic diversity in cytotoxin-producing and non-cytotoxin-producing Helicobacter pylori strains
217. Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from China
218. Expanding allelic diversity of Helicobacter pylori vacA
219. Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases
220. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains
221. Differences in genotypes of Helicobacter pylori from different human populations
222. Geographic distribution of vacA allelic types of Helicobacter pylori
223. Helicobacters are indigenous to the human stomach: Duodenal ulceration is due to changes in gastric microecology in the modern era
224. Current regimens for treatment of Helicobacter pylori infection
225. The future of Helicobacter pylori eradication: A personal perspective
226. Clinical relevance of resistant strains of Helicobacter pylori: A review of current data
227. A systematic review of Helicobacter pylori eradication therapy the impact of antimicrobial resistance of eradication rates
228. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori
229. Antimicrobial susceptibility pattern & biotyping of Helicobacter pylori isolates from patients with peptic ulcer diseases
230. In vitro sensitivity of Helicobacter pylori in India
231. Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan
232. Drug resistance in Helicobacter pylori infection
233. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori
234. Geographical distribution in the United States of primary resistance to clarithromycin and metronidazole in patients infected with Helicobacter pylori
235. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil
236. Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high level metronidazole resistance in Helicobacter pylori
237. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase
238. Mouse-colonizing Helicobacter pylori SSI is unusually susceptible to metronidazole due to two complementary reductase activities
239. Roles of FrxA and RdxA nitro reductases of Helicobacter pylori in susceptibility and resistance to metronidazole
240. Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium
241. Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation
242. Antibiotic resistance in Helicobacter pylori: Implications for therapy
243. Antimicrobial resistance in Helicobacter pylori: A global overview
244. Stable amoxicillin resistance in Helicobacter pylori
245. Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection
246. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori
247. + (nitroreductase) gene
248. Vaccination against Helicobacter pylori - An old companion of man